Data-Driven Drug Development
02 October 2019 - 03 October 2019
Introducing D4 (Data Driven Drug Discovery & Development) Europe, a ground-breaking, innovative event packed with evidence, data and case studies designed to inspire you into action that you can take now, within your own business.
At most existing pharma/data events, you’re lucky to leave with just a couple of interesting case studies relevant to your own work. At D4 Europe every presentation has been carefully crafted to include case study data, evidence, lessons learned, insights, advice and intelligence to take your data-driven projects forward.
Hyperion Hotel Basel, Switzerland
https://www.d4-europe.com/?utm_source=flg&utm_medium=email&utm_campaign=1-launch
Data-Driven Drug Development
02 October 2019 - 03 October 2019
Introducing D4 (Data Driven Drug Discovery & Development) Europe, a ground-breaking, innovative event packed with evidence, data and case studies designed to inspire you into action that you can take now, within your own business.
At most existing pharma/data events, you’re lucky to leave with just a couple of interesting case studies relevant to your own work. At D4 Europe every presentation has been carefully crafted to include case study data, evidence, lessons learned, insights, advice and intelligence to take your data-driven projects forward.
Hyperion Hotel Basel, Switzerland
https://www.d4-europe.com/?utm_source=flg&utm_medium=email&utm_campaign=1-launch
Wearable Injectors and Connected Devices Conference 2019
09 October 2019 - 10 October 2019
SMi is proud to present the inaugural Wearable Injectors and Connected Devices Conference, taking place on the 9th-10th October 2019, in London.
The global wearable devices market size is expected to reach a value of $12.1 billion USD by 2021 with time dependent delivery, large volume administration with minimal injection pain and the use of connectivity to enhance user-value being key factors driving the market.
With this in mind, the conference will explore new technologies and advances of on-body devices for the administration of viscous and large molecule drug delivery, and evaluate the impact of IoT, connectivity and enhancement of user-interface, which make up core components within the wearable devices field.
Copthorne Tara Hotel, London, UK
http://www.wearable-injectors.co.uk/DDTwl
Pharmaceutical Manufacturing and Cleanroom Technology
09 October 2019 - 10 October 2019
SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, taking place on the 9th and 10th October 2019 in London, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.
This one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals, biologicals, and cleanroom industry experts to explore hot topics within cleanroom design and engineering, best practices and regulation, environmental and contamination control, and pharmaceutical microbiology.
In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals, technological advancements in cleanrooms, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market.
Compliance with the standards for product approvals is crucial and as a result manufacturing companies in various industries are dependent on cleanroom technology.
Copthorne Tara Hotel, London, UK
http://www.cleanroomtechnology.co.uk/drugdiscoverytoday
3rd European Prefilled Syringes Summit
09 October 2019 - 10 October 2019
The two day event will explore the advancements in regulatory guidelines including Article 117 and what this will mean for interactions with notified bodies. The conference will highlight technical advancements in product design and usage, looking at the move towards autoinjectors. Our expert speakers will compare the use of glass syringes with plastic syringes, focus on how to minimise the impact of extractables and leachables, and address CCI regulations. Through in-depth presentations and interactive panel discussions, the conference will shed light onto how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
tbc Berlin, Germany
http://www.wplgroup.com/aci/event/european-prefilled-syringes-summit/
Bioforward 2019
11 October 2019
BioForward is aimed at professionals from early stage and emerging life sciences companies who want to gain the knowledge, skills, connectivity and support necessary to achieve commercial success for their organisation.
What's included?
Panel discussions sharing expert insight and opinion on the most important issues facing the industry
A targeted series of 'How To' discussions led by experts addressing a range of hot topics
An exhibition featuring specialist companies to support your growth, including: preclinical and clinical development, IP, regulatory compliance, insurance, facilities, manufacturing, communications, new technology and talent
Access to our partnering platform for private meetings, along with plenty of networking opportunities throughout the day
To view our delegate ticket rates and register please head to our registration page. If you have any queries please contact events@obn.org.uk or call +441235 420 870
Aston Webb Building, Birmingham, UK
https://bioforward.co.uk/
SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
15 October 2019 - 16 October 2019
SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK.
The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.
This is due to the arising interest from pharmaceutical companies for underlying benefits, such as the potential discovery of mechanisms for more common diseases, and also the involvement of many smaller biotechnology start-up companies who are primarily focused on rare diseases.
The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerate orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.
Holiday Inn Kensington Forum, London, UK
http://www.orphandrugs.co.uk/drugdiscoverytoday
Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference
21 October 2019 - 22 October 2019
SMi is delighted to announce its USA Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21th-22th October 2019.
The inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? These questions will be answered along with unique insights including HPAPI manufacturing technologies.
Attend the conference and join our networking platform with industry professionals to provide you with the expertise to overcome challenges.
Sheraton Boston Hotel, Boston, MA, USA
http://www.hpapi-usa.com/DDTwb
Lyophilisation USA
23 October 2019 - 24 October 2019
The SMi Group is pleased to invite you to the 5th Annual Lyophilization USA Conference arranged to take place on the 23rd and 24th October 2019, in Boston.
The current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution. This instability or degradation can result in suboptimal product performance and even toxicity in worst cases indicating the need for lyophilization despite it’s inherently expensive running costs and time-consuming process.
Join us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of lyophilization. Benchmark and network with industry leaders and discuss the most up to date and relevant topics that delve into alternative lyophilization approaches, applied statistical modelling, fresh views on scaling up and tech transfer, pre- and post-product characterization. regulation and beyond.
Sheraton Boston Hotel, Boston, MA, USA
https://www.smi-online.co.uk/pharmaceuticals/northamerica/Lyophilisation-USA?utm_medium=www.lyophilisation-usa.com&utm_source=P-325&utm_campaign=DDT
Exploring Human Host-Microbiome Interactions in Health and Disease
23 October 2019 - 25 October 2019
Alterations in microbiome composition have been associated with many non-infectious diseases including inflammatory bowel conditions, autoimmune diseases, cancers and diabetes. The 8th Exploring Human Host-Microbiome Interactions in Health and Disease meeting will bring together leading scientists and clinicians from the fields of microbiology, gastroenterology, neuroscience, and cancer to discuss the latest developments in this fast-moving area.
The conference will update current knowledge of how various microbiomes (skin, oral, gut, lung, non-bacterial etc.) communicate with the host and the factors that influence these interactions. The programme will feature new developments enabled by metagenomics, metabonomics and other technologies. Attendees can participate in discussions on how to apply recent discoveries to disease processes, health restoration and maintenance. This year’s meeting will also include sessions on the effects of the microbiome on cancer and how the immune system influences the microbiome and vice versa.
Deadlines: Early bird: 30 Jul | Abstract: 10 Sept |Registration: 24 Sept
Wellcome Genome Campus, UK
https://coursesandconferences.wellcomegenomecampus.org/our-events/exploring-human-host-microbiome-interactions-2019/
Lab Innovations
30 October 2019 - 31 October 2019
Lab Innovations is the UK’s largest annual trade exhibition dedicated to the entire laboratory industry, uniting +3,000 laboratory decision makers with +160 laboratory suppliers and manufacturers across all sectors. Held at Birmingham’s NEC, it is central to the UK’s science and manufacturing industry. Visitors can see and source innovative new technologies, network with peers and earn CPD points in the free-to-attend conference programme. Content is current, for example with sustainability a high priority, new feature areas and seminar topics will outline how to keep laboratory procurement green. Supported by some of the UK’s top science institutions, it is a key event for powering the business of science.
NEC, Birmingham, UK
https://www.easyfairs.com/lab-innovations-2019/lab-innovations-2019/?utm_source=Drug%20Discovery%20Today